Literature DB >> 3382595

The effect of metoclopramide on the absorption of oral controlled release morphine.

A R Manara1, M P Shelly, K Quinn, G R Park.   

Abstract

The pharmacokinetics of oral controlled release morphine and metoclopramide were investigated in 20 patients in a double-blind, randomly allocated study. The concurrent administration of metoclopramide and oral controlled release morphine led to a faster onset and increased level of sedation compared with the administration of oral controlled release morphine alone. Whilst the increased sedation may be advantageous in anaesthetic practice, it may be a potential problem in patients starting longer term therapy with these drugs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3382595      PMCID: PMC1387816          DOI: 10.1111/j.1365-2125.1988.tb03338.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  The reliability of a linear analogue for evaluating pain.

Authors:  S I Revill; J O Robinson; M Rosen; M I Hogg
Journal:  Anaesthesia       Date:  1976-11       Impact factor: 6.955

2.  Analgesic effect of morphine glucuronides.

Authors:  K Shimomura; O Kamata; S Ueki; S Ida; K Oguri; H Yoshimura; H Tsukamoto
Journal:  Tohoku J Exp Med       Date:  1971-09       Impact factor: 1.848

3.  Premedication by controlled-release morphine.

Authors:  B Kay; T E Healy
Journal:  Anaesthesia       Date:  1984-06       Impact factor: 6.955

4.  Controlled release morphine sulphate tablets--a study in normal volunteers.

Authors:  S T Leslie; A Rhodes; F M Black
Journal:  Br J Clin Pharmacol       Date:  1980-05       Impact factor: 4.335

5.  High-pressure liquid chromatographic method for determination of metoclopramide in serum, urine, and saliva, with a pharmacokinetic study in patients.

Authors:  J Popović
Journal:  Ther Drug Monit       Date:  1984       Impact factor: 3.681

Review 6.  Metoclopramide: a review of its pharmacological properties and clinical use.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

7.  Postoperative gastric emptying.

Authors:  D M Ingram; H J Sheiner
Journal:  Br J Surg       Date:  1981-08       Impact factor: 6.939

8.  Pharmacokinetics and analgesic effect of slow-release oral morphine sulphate in volunteers.

Authors:  M Vater; G Smith; G W Aherne; A R Aitkenhead
Journal:  Br J Anaesth       Date:  1984-08       Impact factor: 9.166

Review 9.  Metoclopramide: pharmacology and clinical application.

Authors:  R Albibi; R W McCallum
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

10.  Analgesic effect of metoclopramide and its mechanism.

Authors:  S Ramaswamy; J S Bapna
Journal:  Life Sci       Date:  1986-04-07       Impact factor: 5.037

View more
  6 in total

Review 1.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 2.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 3.  Pharmacokinetic drug interactions with gastrointestinal motility modifying agents.

Authors:  J M Greiff; D Rowbotham
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

Review 4.  Drug interactions of clinical significance with opioid analgesics.

Authors:  P M Maurer; R R Bartkowski
Journal:  Drug Saf       Date:  1993-01       Impact factor: 5.606

Review 5.  Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management.

Authors:  Xiu-Qin Feng; Ling-Ling Zhu; Quan Zhou
Journal:  J Pain Res       Date:  2017-05-24       Impact factor: 3.133

Review 6.  Organic Cation Transporter 1 an Intestinal Uptake Transporter: Fact or Fiction?

Authors:  Christoph Wenzel; Marek Drozdzik; Stefan Oswald
Journal:  Front Pharmacol       Date:  2021-04-14       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.